Arvinas Inc [ARVN] stock is trading at $7.28, up 8.89%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ARVN shares have gain 9.71% over the last week, with a monthly amount drifted -20.90%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Arvinas Inc [NASDAQ: ARVN] stock has seen the most recent analyst activity on May 05, 2025, when Truist downgraded its rating to a Hold but kept the price target unchanged to $11 for it. Previously, TD Cowen downgraded its rating to Hold on May 02, 2025. On May 02, 2025, downgrade downgraded it’s rating to Hold but maintained its price target of $10 on the stock. Goldman downgraded its rating to a Neutral and decreased its price target to $15 on March 13, 2025. Wedbush downgraded its rating to a Neutral and reduced its price target to $12 on March 12, 2025. Oppenheimer downgraded its rating to Perform for this stock on March 11, 2025. In a note dated December 10, 2024, BTIG Research initiated an Buy rating and provided a target price of $69 on this stock.
Arvinas Inc [ARVN] stock has fluctuated between $5.90 and $36.20 over the past year. Currently, Wall Street analysts expect the stock to reach $17 within the next 12 months. Arvinas Inc [NASDAQ: ARVN] shares were valued at $7.28 at the most recent close of the market. An investor can expect a potential return of 133.52% based on the average ARVN price forecast.
Analyzing the ARVN fundamentals
Arvinas Inc [NASDAQ:ARVN] reported sales of 161.00M for the trailing twelve months, which represents a growth of 646.25%. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.11%, and Net Profit Margin reading is -0.11%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is -0.08 and Total Capital is -0.12. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.82 points at the first support level, and at 6.37 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.61, and for the 2nd resistance point, it is at 7.95.
Ratios To Look Out For
For context, Arvinas Inc’s Current Ratio is 4.58. As well, the Quick Ratio is 4.58, while the Cash Ratio is 0.38. Considering the valuation of this stock, the price to sales ratio is 3.30, the price to book ratio is 0.81.
Transactions by insiders
Recent insider trading involved Berkowitz Noah, Chief Medical Officer, that happened on Mar 18 ’25 when 8658.0 shares were sold. Officer, Noah Berkowitz completed a deal on Mar 18 ’25 to buy 8658.0 shares. Meanwhile, Chief Accounting Officer Loomis David K sold 1214.0 shares on Feb 24 ’25.
